Conversation 150: Why G Medical’s news today may be bigger than it appears.

Health
Written By Phil Carey
gmpProd_img.png

Israeli based G Medical [ASX: GMV] told the ASX today that it's been granted US FDA ‘Emergency Use Authorisation’ for one of its products because of shortages caused by US hospital system, overwhelmed by COVID-19 patients.

While there are nearly one and a half million Americans diagnosed with COVID-19, it is very difficult to get an accurate picture of how many people are actually in hospitals.

So just how many G Medical monitoring patches might be used?

Phil Carey https://www.cornerstonemedia.com.au
Previous

Conversation 159: This stock popped 40% in a day. Is it just the beginning?
Next

Conversation 153: InteliCare [ASX:ICR] lists and almost doubles on debut.